Published in Medical Letter on the CDC and FDA, May 23rd, 2004
"The protein called serine repeat antigen (SERA) is a P. falciparum malaria antigen; high activity erythrocyte binding peptides have been identified in this protein. One of these, the 6725 peptide (non-immunogenic and non-protective), was analyzed for immunogenicity and protective activity in Aotus monkeys, together with several of its analogues," investigators in Colombia report.
"These peptides were studied by (HNMR)-H-1 to try to correlate their structure with their biological function,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.